Stewart Murray
Insider CIK 1723450 · XFOR Interim Chief Medical Officer, Director · RYTM Chief Medical Officer · CAMP Director · NVLN Executive Vice President, R&D · AMRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CAMP Camp4 Therapeutics Corp | A Award deriv | 2026-06-10 | 2026-06-12 | 28,000 | — | $0 | 28,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2026-01-01 | 2026-01-05 | 110,000 | — | $0 | 0 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-06-09 | 2025-06-10 | 1,500 | — | $0 | 7,883 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | A Award deriv | 2025-03-17 | 2025-03-19 | 17,787 | — | $0 | 17,787 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2024-06-10 | 2024-06-11 | 45,000 | — | $0 | 191,504 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-08-10 | 2023-08-11 | 130,056 | $1.06 | $137.9K | 146,504 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2023-08-09 | 2023-08-11 | 269,893 | — | $0 | 276,560 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2023-01-09 | 2023-01-12 | 182,433 | — | $0 | 182,433 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2023-01-09 | 2023-01-12 | 223,560 | — | $0 | 223,560 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-06-06 | 2022-06-27 | 6,667 | — | $0 | 6,667 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2021-06-02 | 2021-06-02 | 6,000 | $9.50 | $57.0K | 6,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-02-11 | 2021-02-16 | 56,250 | — | $0 | 56,250 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-02-11 | 2021-02-16 | 9,375 | — | $0 | 9,375 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-10-20 | 2020-10-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-06-30 | 2020-07-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-06-10 | 2020-06-11 | 3,427 | — | $0 | 3,427 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-02-14 | 2020-02-19 | 88,000 | — | $0 | 88,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-03-29 | 2019-04-02 | 6,854 | — | $0 | 6,854 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2019-02-13 | 2019-02-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2018-10-15 | 2018-10-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2018-02-12 | 2018-02-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2017-11-27 | 2017-11-29 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award | 2017-11-27 | 2017-11-29 | 50,000 | — | $0 | 50,000 | SEC↗ |